ARK Investment Management Boosts Stake in Beam Therapeutics

TL;DR

**ARK Invest owns 9.39M shares of Beam Therapeutics as of Dec 31, 2023.**

AI Summary

ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership in Beam Therapeutics Inc. As of December 31, 2023, ARK beneficially owned 9,393,889 shares of Beam Therapeutics' common stock. This filing indicates a significant stake held by a prominent institutional investor, which could signal confidence in the company's future, potentially influencing other investors considering Beam Therapeutics stock.

Why It Matters

This filing shows that a major institutional investor, ARK Investment Management, holds a substantial position in Beam Therapeutics, which can be seen as a vote of confidence and might attract other investors.

Risk Assessment

Risk Level: low — This filing primarily updates an existing ownership stake and does not introduce new significant risks to the company or its investors.

Analyst Insight

A smart investor would note ARK's continued significant stake as a potential positive signal, but should conduct their own due diligence on Beam Therapeutics' fundamentals and future prospects before making any investment decisions.

Key Numbers

• 9,393,889 — Aggregate Shares Beneficially Owned (This is the total number of Beam Therapeutics shares ARK Investment Management LLC reported owning as of December 31, 2023.)
• 9,127,264 — Sole Voting Power Shares (This represents the number of shares over which ARK Investment Management LLC has exclusive voting control.)
• 136,225 — Shared Voting Power Shares (This indicates the number of shares over which ARK Investment Management LLC shares voting control with others.)
• 9,393,889 — Sole Dispositive Power Shares (This is the number of shares over which ARK Investment Management LLC has exclusive power to sell or dispose of.)
• 0 — Shared Dispositive Power Shares (This shows that ARK Investment Management LLC does not share dispositive power over any shares.)

Key Players & Entities

• ARK Investment Management LLC (company) — the reporting person and institutional investor
• Beam Therapeutics Inc. (company) — the subject company whose shares are being reported
• 9,393,889 (dollar_amount) — aggregate shares beneficially owned by ARK Investment Management LLC
• December 31, 2023 (date) — the date of the event requiring the filing
• Delaware (company) — place of organization for ARK Investment Management LLC

Forward-Looking Statements

• ARK Investment Management will maintain a significant stake in Beam Therapeutics Inc. throughout 2024. (ARK Investment Management LLC) — medium confidence, target: December 31, 2024

FAQ

Filing Documents

• tm244117d10_sc13ga.htm (SC 13G/A) — 50KB
• 0001104659-24-007680.txt ( ) — 52KB

(a) Name of issuer

Item 1(a) Name of issuer: Beam Therapeutics Inc.

(b) Address of issuer's

Item 1(b) Address of issuer's principal executive offices: 26 Landsdowne Street, Cambridge, MA 02139

(a) Name of person filing

Item 2(a) Name of person filing: ARK Investment Management LLC

(b) Address or principal

Item 2(b) Address or principal business office or, if none, residence: ARK Investment Management LLC 200 Central Avenue St. Petersburg, FL 33701

(c) Citizenship

Item 2(c) Citizenship: Delaware, United States

(d) Title of class of

Item 2(d) Title of class of securities: Common stock

(e) CUSIP No

Item 2(e) CUSIP No.: 07373V105

If this statement is filed

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 07373V105 13G Page 4 of 5 Pages

Ownership

Item 4. Ownership (a) Amount beneficially owned: 9,393,889 (b) Percent of class: 11.53% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 9,127,264 (ii) Shared power to vote or to direct the vote: 136,225 (iii) Sole power to dispose or to direct the disposition of: 9,393,889 (iv) Shared power to dispose or to direct the disposition of: 0

Ownership of 5 Percent or

Item 5. Ownership of 5 Percent or Less of a Class. Not applicable.

Ownership of More than 5 Percent on Behalf of Another Person

Item 6. Ownership of More than 5 Percent on Behalf of Another Person. To the knowledge of the Reporting Person, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the shares which represents more than five percent of the number of outstanding class of the shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 07373V105 13G Page 5 of 5 Pages

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The reporting persons agree that this statement is filed on behalf of each of them. Dated: January 29, 2024 ARK Investment Management LLC By: /s/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer